Christopherd T. Guiffre

Senior Vice President, Cubist Pharmaceuticals.

Companies

Pear Therapeutics (United States)Chief financial officer Dec 7, 2021 to Feb 17, 2023¹
Pear Therapeutics (United States)Chief operating officer Dec 7, 2021 to Feb 17, 2023¹
Dare Bioscience, Inc.Board member Mar 25, 2015 to Jan 9, 2017²
Dare Bioscience, Inc.Chief executive officer Mar 25, 2015 to Jan 9, 2017²
Dare Bioscience, Inc.Chief operating officer Oct 31, 2014 to Feb 9, 2015³
Dare Bioscience, Inc.Sr. VP, Chief Business Officer Apr 10, 2014 to Jun 26, 2014⁴
Cubist PharmaceuticalsSenior Vice President Jan 5, 2006 to Apr 2, 2008⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 20, 2023Sold 19,540 shares at $1.13 of Pear Therapeutics (United States)⁶
Jan 14, 2023Exercised options 49,500 shares of Pear Therapeutics (United States)⁷

The numbers on this page point here. Each one links to the record it came from.